Navigation Links
Pfizer-Pharmacia Fallout Gives Celltech A CEO

New York, NY - One certain consequence of the nearly $60 billion acquisition of Pharmacia by Pfizer: executive-suite cleaning. The first bigwig out the door is Dr. Gran Ando, who headed up Peapack, N.J.-based Pharmacia's research and development operations. Today, Celltech, one of Europe's biggest biotechnology companies, announced Ando as its new chief executive.

"You will see that the e......

Full article >>> linical trials, and is being co-developed by Merck (nyse: MRK). A drug licensed into Pharmacia's pipeline from Altana (nyse: AAA) will compete directly with Celltech's asthma product.

Celltech's sales come mainly from aging products--the biggest is a cough medicine--that it bought to allow it to keep running without infusions of venture capital. "A couple of years ago Celltech made the st......

Full article >>>
'"/>

Source:wistechnology.com By Matthew Herper, Forbes.com 04/28/03


Related biology technology :

1. Who Gives a Blog?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... ... January 11, 2017 , ... ... Research show early promise of the investigational anti-cancer agent tucatinib (formerly ONT-380) against ... previous treatment regimens. Twenty-seven percent of these heavily pretreated patients saw clinical benefit ...
(Date:1/11/2017)... , ... January 11, 2017 , ... ... year and costing healthcare systems more than $23.7 billion, healthcare systems are ... , Among the most common sepsis-causing pathogens are bacteria and the yeast ...
(Date:1/11/2017)... ... 11, 2017 , ... Symbios Technologies, Inc., a ... Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) ... the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer ...
(Date:1/11/2017)... 11, 2017  GenVec, Inc. (NASDAQ: ... today that its chief scientific officer, Douglas ...  "AdenoVerse™ platform for translational development of innovative gene ... the upcoming Phacilitate Cell & Gene Therapy World ... Florida.  Dr. Brough,s presentation will highlight the utility ...
Breaking Biology Technology:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... -- Michael Johnson, co-founder of Visikol Inc. a company originally funded with ... to the elite "Forbes 30 Under 30" list in the Science ... 20 fields nationwide to be recognized as a leader in business ... ... a PhD candidate at Rutgers University. Visikol ...
(Date:1/4/2017)... thousands of attendees at this year,s International Consumer Electronics Show (CES), ... devices and services, will be featuring its new line of ULTRA CONNECT ... special CES Exhibit Suite , the new upper arm and wrist smart ... product platform.  Continue Reading ... ...
Breaking Biology News(10 mins):